BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38488049)

  • 1. Adherence to Growth Hormone Treatment in Children During COVID-19 Pandemic.
    Eren E; Çetinkaya S; Denkboy Ongen Y; Tercan U; Darcan Ş; Turan H; Aydın M; Yavuzyılmaz F; Kilci F; Selver Eklioğlu B; Hatipoğlu N; Yuksek Acinikli K; Orbak Z; Çamtosun E; Savaş Erdeve Ş; Arslan E; Ercan O; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2024 Mar; ():. PubMed ID: 38488049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yearly Height Gain Is Dependent on the Truly Received Dose of Growth Hormone and the Duration of Periods of Poor Adherence: Practical Lessons From the French Easypod™ Connect Multicenter Observational Study.
    Coutant R; Nicolino M; Cammas B; de Buyst V; Tauber M; Hamel JF
    Front Endocrinol (Lausanne); 2021; 12():790169. PubMed ID: 35126310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PREVALENCE AND CORRELATES OF ADHERENCE IN CHILDREN AND ADOLESCENTS TREATED WITH GROWTH HORMONE: A MULTICENTER ITALIAN STUDY.
    Bagnasco F; Di Iorgi N; Roveda A; Gallizia A; Haupt R; Maghnie M;
    Endocr Pract; 2017 Aug; 23(8):929-941. PubMed ID: 28614005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to growth hormone therapy: results of a multicenter study.
    Aydın BK; Aycan Z; Sıklar Z; Berberoğlu M; Ocal G; Cetinkaya S; Baş VN; Kendirci HN; Cetinkaya E; Darcan S; Gökşen D; Evliyaoğlu O; Sükür M; Baş F; Darendeliler F
    Endocr Pract; 2014 Jan; 20(1):46-51. PubMed ID: 24013997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS).
    Centonze C; Guzzetti C; Orlando G; Loche S;
    J Endocrinol Invest; 2019 Oct; 42(10):1241-1244. PubMed ID: 30968283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 11. Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study.
    Boretzki J; Wolf E; Wiese C; Noe S; Balogh A; Meurer A; Krznaric I; Zink A; Lersch C; Spinner CD
    Patient Prefer Adherence; 2017; 11():1897-1906. PubMed ID: 29184394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric growth hormone treatment in Italy: A systematic review of epidemiology, quality of life, treatment adherence, and economic impact.
    Orso M; Polistena B; Granato S; Novelli G; Di Virgilio R; La Torre D; d'Angela D; Spandonaro F
    PLoS One; 2022; 17(2):e0264403. PubMed ID: 35213607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3M syndrome: Evaluating the clinical and laboratory features and the response of the growth hormone treatment: Single center experience.
    Karacan Küçükali G; Keskin M; Aycan Z; Savaş-Erdeve Ş; Çetinkaya S
    Eur J Med Genet; 2023 Oct; 66(10):104828. PubMed ID: 37673300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Growth Hormone Results in Different Diagnosis and Trend Over 10 Year of Follow-up: A Single Center Experience.
    Aycan Z; Araslı Yılmaz A; Yel S; Savaş-Erdeve Ş; Çetinkaya S
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):332-341. PubMed ID: 33749217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F; Lindberg A; Wilton P
    Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial patient choice of a growth hormone device improves child and adolescent adherence to and therapeutic effects of growth hormone replacement therapy.
    Gau M; Takasawa K
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):989-993. PubMed ID: 28771439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.